Navigation Links
Ban On Trans Fats Comes Into Effect From July 1

Trans fats are chemically modified fats rich in cholesterol and known to cause heart disease. They are widely used as a substitute for saturated fats in bakery products//, fried foods like chips, salad dressings and other foods since long. Food prepared using trans fats is also believed to have a longer shelf life.

In a mighty effort to fight Obesity, the members of the New York City Board of Health, voted yesterday to ban the use of huge amounts of artificial trans fats in restaurants and bakeries.

Experts believe that eliminating trans fats will not change the taste of foods, but chefs and restaurant owners disagree, saying it will be difficult and more expensive to replicate the taste and texture of some menu items without them.

The health department’s restaurant inspectors will be in charge of enforcing both the trans fat and calorie regulations. Violators would have to face fines greater than $200. The Board of Health also demands that restaurants, especially fast food outlets, display the calorific value of each menu item on display boards.

The restaurant industry is highly agitated and accuses the government of interference into free enterprise and civil liberties.

“This is a misguided attempt at social engineering by a group of physicians who don’t understand the restaurant industry,” said Dan Flesher, a representative of National Restaurant Association. He said the association would challenge one or both measures legally.

Mayor Bloomberg said, “ the city is not going to take away anybody’s ability to go out and have the kind of food they want, in the quantities they want.”

“We are just trying to make food safer,” he added.

Restaurants have time until next July 1 to reduce usage of oils and margarine. Admissible fat level is a half-gram of trans fat per serving.

Posting caloric content also takes effect next July 1, this should not be a matter of co ncern for large chains restaurants with highly standardized menus.

Source-Medindi
PRI
'"/>




Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with CAD
2. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
3. Stem Cell Transplants May Be Effective For MS Patients
4. Transforming stem cells to lung cells
5. Alternative to blood Transfusions
6. Need for Blood Transfusions reduced
7. Drugs Deter Heart Disease for Transplant Patients
8. Better Drug for Heart Transplant
9. Kidney Failure after Non-Kidney Transplants
10. Measles Risk in Transplant Patients
11. West Nile and Blood Transfusions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Manju R. Kejriwal, ... ClearCorrect orthodontics, with or without a referral. Dr. Kejriwal understands the emotional and ... convenient, clear braces in Cincinnati, OH. Patients no longer need to feel the esthetic ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... II of the HP3 (High-Performance Periodontal Practice) continuing education (CE) series. As a ... advancements in his field by attending numerous CE courses each year. His recent ...
(Date:5/24/2017)... ... 2017 , ... If you are thinking of a visit to San Francisco , fall ... the perfect time to visit. , Business Architecture Associates is pleased to offer 5 days ... as a 4-½ day package for individuals, and as 4-½ day corporate package for up ...
(Date:5/24/2017)... ... May 24, 2017 , ... Fiberstar, ... solutions for the food and beverage industry offers Citri-Fi®, a natural citrus fiber, ... the purchasing decision process. As a result, labels need to deliver simple, transparent ...
(Date:5/23/2017)... ... ... Axiad IDS , a leading provider of trusted identities for enterprise, ... a “Top 25 Cybersecurity Companies 2017.” Axiad IDS received this honor in ... address potential cybersecurity threats before they happen. The annual list of top ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a ... and developing novel compounds to treat Parkinson,s disease (PD), ... study is a Phase 1/2a randomized, controlled, multicenter study involving ... It will enroll 50 patients over a 9-to-12-month period. The ... in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... , May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of ... is based on extensive data analysis from GHI,s hospitals ... hospitals database for the region. The GHI database covers 86% ... offering more than 130 data points for each institution in ...
(Date:5/9/2017)... May 9, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, today announced it has earned a spot on ... list. The Company was ranked among 500 U.S. employers ... and Healthcare Equipment and Services. The annual ... an anonymous, independent survey of over 30,000 employees across ...
Breaking Medicine Technology: